Analysts’ Viewpoint on Global Market Scenario
Rise in prevalence of cardiovascular diseases is expected to propel thrombectomy devices market statistics during the forecast period. Thrombectomy devices are commonly used in the treatment of stroke, deep vein thrombosis, and pulmonary embolism. Increase in aging population is a major factor fueling demand for these devices worldwide.
Leading companies in the market are increasingly investing in R&D of new diagnostic technologies. Key players are launching advanced rapid diagnostic tests in order to increase their thrombectomy devices Industry share. Prominent manufacturers are engaged in introducing innovative thrombectomy devices such as mechanical/fragmentation thrombectomy. Demand for automated thrombectomy devices is anticipated to rise in the near future. This factor is presenting incremental business opportunities for thrombectomy devices market players.
Thrombectomy devices are medical instruments used to remove blood clots from arteries and veins. A blood clot, also known as a thrombus, can cause a blockage in a blood vessel, leading to serious medical conditions such as stroke, heart attack, or pulmonary embolism.
Thrombectomy devices are used to remove these clots, allowing blood to flow freely and restoring normal blood circulation. These devices can be used in different parts of the body, such as the brain, heart, and lungs. Aspiration thrombectomy devices, mechanical/fragmentation thrombectomy devices, rheolytic/hydrodynamic thrombectomy devices, and ultrasound-assisted thrombectomy devices are some of the major types of thrombectomy devices.
The thrombectomy devices industry is expanding due to the increase in prevalence of cardiovascular diseases worldwide. Cardiovascular diseases (CVDs) are a group of disorders that affect the heart and blood vessels. They include conditions such as coronary artery disease, heart failure, and stroke.
According to the World Health Organization (WHO), CVDs are the leading cause of death globally, accounting for an estimated 17.9 million deaths in 2019. The prevalence of CVDs is increasing, worldwide, largely due to lifestyle changes such as unhealthy diets, physical inactivity, and tobacco usage. Moreover, several risk factors for CVDs can increase a person's likelihood of developing the condition. These include high blood pressure, high cholesterol, diabetes, obesity, and a family history of heart disease.
According to the American Heart Association (AHA), in the U.S. alone, one person dies from CVD every 36 seconds. That's approximately 655,000 deaths per year, or one in every four deaths. Furthermore, about 121.5 million adults in the U.S., or nearly half of all adults in the U.S., have some form of CVD. In developing countries, CVDs are also becoming more prevalent. The WHO estimates that 80.0% of CVD deaths occur in low- and middle-income countries due to tobacco consumption and inactive lifestyles. Therefore, the rise in the rate of CVDs is a major factor that is expected to fuel the demand for thrombectomy devices market in the next few years.
According to the United Nations, the world's population is aging, with the number of people aged 60 years and over expected to double by 2050. This demographic shift is expected to have a significant impact on healthcare systems and economies, worldwide, including increased demand for healthcare services and changes in workforce participation and retirement patterns.
One of the major health consequences of an aging population is an increased prevalence of chronic diseases, such as cardiovascular disease, cancer, and dementia. These conditions can have a significant impact on quality of life and can require ongoing medical care and support.
Additionally, older adults are more likely to experience multiple chronic conditions, known as multimorbidity, which can complicate treatment and increase healthcare costs.
According to the World Health Organization (WHO), noncommunicable diseases, including chronic diseases, are the leading cause of death worldwide, and accounted for an estimated 41 million deaths in 2018. The WHO also stated that the burden of noncommunicable diseases is increasing in low- and middle-income countries, which are witnessing the most rapid growth of the geriatric population.
Thrombectomy devices can be particularly important for older adults, who may be more susceptible to stroke and may have more severe strokes. A 2018 study published in the Journal of the American Geriatrics Society found that older adults were less likely to receive thrombectomy treatment for stroke than younger patients, despite evidence that thrombectomy is effective for this population. The study suggested that age bias may be a factor in the underuse of thrombectomy treatment in older adults.
According to the latest thrombectomy devices strategic business report analysis, the mechanical/fragmentation thrombectomy devices product type segment held major share of the global thrombectomy devices market in 2022. Increase in prevalence of cardiovascular diseases is likely to drive this segment. Mechanical thrombectomy devices mechanically remove blood clots from blood vessels. These devices physically remove the clot from the vessel, either by suction or by fragmenting the clot into smaller pieces so that it can be easily removed.
Mechanical/fragmentation thrombectomy devices are commonly utilized in the treatment of stroke - a medical emergency that occurs when blood flow to the brain is blocked by a clot or other obstruction. According to the World Health Organization, stroke is the second-leading cause of death and the third-leading cause of disability worldwide.
Various types of mechanical/fragmentation thrombectomy devices are available on the market, including stent retrievers, aspiration catheters, and rotational thrombectomy devices. Stent retrievers, which are among the most commonly used devices, work by trapping the clot in a stent-like device and then removing the stent, along with the clot, from the vessel. Aspiration catheters use suction to remove the clot, while rotational thrombectomy devices use a rotating wire to fragment the clot.
The automated device type segment is likely to account for a major share of the thrombectomy devices market during the forecast period. Automated thrombectomy devices make use of mechanical or suction-based technology to remove blood clots from blood vessels in a minimally invasive manner. These devices are commonly used in the treatment of stroke, deep vein thrombosis, and other conditions caused due to blood clots.
Automated thrombectomy devices offer several advantages over traditional surgical methods, including reduced invasiveness, shorter recovery time, and improved patient outcomes. These devices also allow for greater precision and control during the removal of blood clots, which can help to minimize damage to the surrounding tissue and reduce the risk of complications. The thrombectomy devices market size is projected to increase during the forecast period, owing to the rise in adoption of automated devices.
North America held largest share of around 30.0% of the global market in 2022. The region is expected to be a highly lucrative market during the forecast period. Thrombectomy devices market growth in North America is majorly ascribed to the increase in incidence of cardiovascular diseases such as high blood pressure and cardiac arrest. The U.S. dominated the market in North America owing to the presence of major market players and increase in research and development activities in the field of thrombectomy devices.
Asia Pacific is projected to be the fastest growing market during the forecast period. The market in the region is anticipated to grow at a high CAGR from 2023 to 2031, owing to the high incidence rate of cardiovascular diseases in the region. Rapidly growing population is also contributing to the future expansion of thrombectomy devices market in the region.
The global market for thrombectomy devices is fragmented, with the presence of a large number of players. According to the industry forecast of thrombectomy devices, leading players are implementing various strategies to increase their market share. These players are expanding their product portfolio by following the thrombectomy devices market trends and focusing on mergers & acquisitions to gain revenue benefits. Key organizations are making significant investments in research & development to develop innovative tests such as rapid tests.
Stryker Corporation, Boston Scientific Corporation, Medtronic plc, Terumo Corporation, Johnson & Johnson, Teleflex Incorporated, Argon Medical Devices Inc, Edwards Lifesciences Corporation, Koninklijke Philips N.V., and Penumbra, Inc. are some of the prominent players operating in this market.
Key players have been profiled in the thrombectomy devices industry forecast report based on parameters such as company overview, business strategies, product portfolio, business segments, and recent developments.
|
Attribute |
Detail |
|
Market Size Value in 2022 |
US$ 1.7 Bn |
|
Market Forecast Value in 2031 |
More than US$ 3.4 Bn |
|
Growth Rate (CAGR) |
7.3% |
|
Forecast Period |
2023–2031 |
|
Historical Data Available for |
2017–2021 |
|
Quantitative Units |
US$ Bn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
The global market was valued at US$ 1.7 Bn in 2022.
It is projected to reach more than US$ 3.4 Bn by 2031.
The market is anticipated to advance at a CAGR of 7.3% from 2023 to 2031.
Growth in prevalence of cardiovascular diseases and rise in aging population.
North America is likely to account for major share during the forecast period.
Stryker Corporation, Boston Scientific Corporation, Medtronic plc, Terumo Corporation, Johnson & Johnson, Teleflex Incorporated, Argon Medical Devices Inc, Edwards Lifesciences Corporation, Koninklijke Philips N.V., and Penumbra, Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Thrombectomy Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Thrombectomy Devices Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Technological Advancements
5.2. Pricing Analysis
5.3. Reimbursement Scenario by Region/Globally
5.4. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)
6. Global Thrombectomy Devices Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Aspiration Thrombectomy Devices
6.3.2. Mechanical/Fragmentation Thrombectomy Devices
6.3.2.1. Coil Retrievers
6.3.2.2. Basket/Brush Retrievers
6.3.2.3. Stent Retrievers
6.3.3. Rheolytic/Hydrodynamic Thrombectomy Devices
6.3.4. Ultrasound-assisted Thrombectomy Devices
6.4. Market Attractiveness Analysis, by Product Type
7. Global Thrombectomy Devices Market Analysis and Forecast, by Device Type
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Device Type, 2017–2031
7.3.1. Automated
7.3.2. Manual
7.4. Market Attractiveness Analysis, by Device Type
8. Global Thrombectomy Devices Market Analysis and Forecast, by Application
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Application, 2017–2031
8.3.1. Cardiovascular Thrombectomy
8.3.2. Neurovascular Thrombectomy
8.3.3. Peripheral Vascular Thrombectomy
8.4. Market Attractiveness Analysis, by Application
9. Global Thrombectomy Devices Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Hospitals and Specialty Clinics
9.3.2. Ambulatory Surgery Centers
9.3.3. Others
9.4. Market Attractiveness Analysis, by End-user
10. Global Thrombectomy Devices Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2017–2031
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness By Country/Region
11. North America Thrombectomy Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2031
11.2.1. Aspiration Thrombectomy Devices
11.2.2. Mechanical/Fragmentation Thrombectomy Devices
11.2.2.1. Coil Retrievers
11.2.2.2. Basket/Brush Retrievers
11.2.2.3. Stent Retrievers
11.2.3. Rheolytic/Hydrodynamic Thrombectomy Devices
11.2.4. Ultrasound-assisted Thrombectomy Devices
11.3. Market Value Forecast, by Device Type, 2017–2031
11.3.1. Automated
11.3.2. Manual
11.4. Market Value Forecast, by Application, 2017–2031
11.4.1. Cardiovascular Thrombectomy
11.4.2. Neurovascular Thrombectomy
11.4.3. Peripheral Vascular Thrombectomy
11.5. Market Value Forecast, by End-user, 2017–2031
11.5.1. Hospitals and Specialty Clinics
11.5.2. Ambulatory Surgery Centers
11.5.3. Others
11.6. Market Value Forecast, by Country/Sub-region, 2017–2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Product Type
11.7.2. By Device Type
11.7.3. By Application
11.7.4. By End-user
11.7.5. By Country/Sub-region
12. Europe Thrombectomy Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. Aspiration Thrombectomy Devices
12.2.2. Mechanical/Fragmentation Thrombectomy Devices
12.2.2.1. Coil Retrievers
12.2.2.2. Basket/Brush Retrievers
12.2.2.3. Stent Retrievers
12.2.3. Rheolytic/Hydrodynamic Thrombectomy Devices
12.2.4. Ultrasound-assisted Thrombectomy Devices
12.3. Market Value Forecast, by Device Type, 2017–2031
12.3.1. Automated
12.3.2. Manual
12.4. Market Value Forecast, by Application, 2017–2031
12.4.1. Cardiovascular Thrombectomy
12.4.2. Neurovascular Thrombectomy
12.4.3. Peripheral Vascular Thrombectomy
12.5. Market Value Forecast, by End-user, 2017–2031
12.5.1. Hospitals and Specialty Clinics
12.5.2. Ambulatory Surgery Centers
12.5.3. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Product Type
12.7.2. By Device Type
12.7.3. By Application
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Thrombectomy Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. Aspiration Thrombectomy Devices
13.2.2. Mechanical/Fragmentation Thrombectomy Devices
13.2.2.1. Coil Retrievers
13.2.2.2. Basket/Brush Retrievers
13.2.2.3. Stent Retrievers
13.2.3. Rheolytic/Hydrodynamic Thrombectomy Devices
13.2.4. Ultrasound-assisted Thrombectomy Devices
13.3. Market Value Forecast, by Device Type, 2017–2031
13.3.1. Automated
13.3.2. Manual
13.4. Market Value Forecast, by Application, 2017–2031
13.4.1. Cardiovascular Thrombectomy
13.4.2. Neurovascular Thrombectomy
13.4.3. Peripheral Vascular Thrombectomy
13.5. Market Value Forecast, by End-user, 2017–2031
13.5.1. Hospitals and Specialty Clinics
13.5.2. Ambulatory Surgery Centers
13.5.3. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Product Type
13.7.2. By Device Type
13.7.3. By Application
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Thrombectomy Devices Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017–2031
14.2.1. Aspiration Thrombectomy Devices
14.2.2. Mechanical/Fragmentation Thrombectomy Devices
14.2.2.1. Coil Retrievers
14.2.2.2. Basket/Brush Retrievers
14.2.2.3. Stent Retrievers
14.2.3. Rheolytic/Hydrodynamic Thrombectomy Devices
14.2.4. Ultrasound-assisted Thrombectomy Devices
14.3. Market Value Forecast, by Device Type, 2017–2031
14.3.1. Automated
14.3.2. Manual
14.4. Market Value Forecast, by Application, 2017–2031
14.4.1. Cardiovascular Thrombectomy
14.4.2. Neurovascular Thrombectomy
14.4.3. Peripheral Vascular Thrombectomy
14.5. Market Value Forecast, by End-user, 2017–2031
14.5.1. Hospitals and Specialty Clinics
14.5.2. Ambulatory Surgery Centers
14.5.3. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Product Type
14.7.2. By Device Type
14.7.3. By Application
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Thrombectomy Devices Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product Type, 2017–2031
15.2.1. Aspiration Thrombectomy Devices
15.2.2. Mechanical/Fragmentation Thrombectomy Devices
15.2.2.1. Coil Retrievers
15.2.2.2. Basket/Brush Retrievers
15.2.2.3. Stent Retrievers
15.2.3. Rheolytic/Hydrodynamic Thrombectomy Devices
15.2.4. Ultrasound-assisted Thrombectomy Devices
15.3. Market Value Forecast, by Device Type, 2017–2031
15.3.1. Automated
15.3.2. Manual
15.4. Market Value Forecast, by Application, 2017–2031
15.4.1. Cardiovascular Thrombectomy
15.4.2. Neurovascular Thrombectomy
15.4.3. Peripheral Vascular Thrombectomy
15.5. Market Value Forecast, by End-user, 2017–2031
15.5.1. Hospitals and Specialty Clinics
15.5.2. Ambulatory Surgery Centers
15.5.3. Others
15.6. Market Value Forecast, by Country/Sub-region, 2017–2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Product Type
15.7.2. By Device Type
15.7.3. By Application
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player – Competition Matrix (by tier and size of companies)
16.2. Market Share Analysis, by Company (2022)
16.3. Company Profiles
16.3.1. Stryker Corporation
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Type Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Boston Scientific Corporation
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Type Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Medtronic plc
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Type Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Terumo Corporation
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Type Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Johnson & Johnson
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Type Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.6. Teleflex Incorporated
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Type Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.7. Argon Medical Devices Inc.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Type Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.8. Edwards Lifesciences Corporation
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Type Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.9. Koninklijke Philips N.V.
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Type Portfolio
16.3.9.3. Financial Overview
16.3.10. Penumbra, Inc.
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Type Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
List of Tables
Table 01: Global Thrombectomy Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 02: Global Thrombectomy Devices Market Value (US$ Mn) Forecast, by Device Type, 2017–2031
Table 03: Global Thrombectomy Devices Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 04: Global Thrombectomy Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 05: Global Thrombectomy Devices Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 06: North America Thrombectomy Devices Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 07: North America Thrombectomy Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 08: North America Thrombectomy Devices Market Value (US$ Mn) Forecast, by Device Type, 2017–2031
Table 09: North America Thrombectomy Devices Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 10: North America Thrombectomy Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 11: Europe Thrombectomy Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 12: Europe Thrombectomy Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 13: Europe Thrombectomy Devices Market Value (US$ Mn) Forecast, by Device Type, 2017–2031
Table 14: Europe Thrombectomy Devices Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 15: Europe Thrombectomy Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 16: Asia Pacific Thrombectomy Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 17: Asia Pacific Thrombectomy Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 18: Asia Pacific Thrombectomy Devices Market Value (US$ Mn) Forecast, by Device Type, 2017–2031
Table 19: Asia Pacific Thrombectomy Devices Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 20: Asia Pacific Thrombectomy Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Latin America Thrombectomy Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Latin America Thrombectomy Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 23: Latin America Thrombectomy Devices Market Value (US$ Mn) Forecast, by Device Type, 2017–2031
Table 24: Latin America Thrombectomy Devices Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 25: Latin America Thrombectomy Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 26: Middle East & Africa Thrombectomy Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 27: Middle East & Africa Thrombectomy Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 28: Middle East & Africa Thrombectomy Devices Market Value (US$ Mn) Forecast, by Device Type, 2017–2031
Table 29: Middle East & Africa Thrombectomy Devices Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 30: Middle East & Africa Thrombectomy Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Thrombectomy Devices Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Global Thrombectomy Devices Market Value Share, by Product Type (2022)
Figure 03: Global Thrombectomy Devices Market Value Share, by Device Type (2022)
Figure 04: Global Thrombectomy Devices Market Value Share, by Application (2022)
Figure 05: Global Thrombectomy Devices Market Value Share, by End-user (2022)
Figure 06: Global Thrombectomy Devices Market Value Share, by Region (2022)
Figure 07: Global Thrombectomy Devices Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 08: Global Thrombectomy Devices Market Attractiveness, by Product Type, 2023–2031
Figure 09: Global Thrombectomy Devices Market Value Share Analysis, by Device Type, 2022 and 2031
Figure 10: Global Thrombectomy Devices Market Attractiveness, by Device Type, 2023–2031
Figure 11: Global Thrombectomy Devices Market Value Share Analysis, by Application, 2022 and 2031
Figure 12: Global Thrombectomy Devices Market Attractiveness, by Application, 2023–2031
Figure 13: Global Thrombectomy Devices Market Value Share Analysis, by End-user, 2022 and 2031
Figure 14: Global Thrombectomy Devices Market Attractiveness, by End-user, 2023–2031
Figure 15: Global Thrombectomy Devices Market Value Share Analysis, by Region, 2022 and 2031
Figure 16: Global Thrombectomy Devices Market Attractiveness, by Region, 2022-2031
Figure 17: North America Thrombectomy Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 18: North America Thrombectomy Devices Market Value Share (%), by Country, 2022 and 2031
Figure 19: North America Thrombectomy Devices Market Attractiveness, by Country, 2023–2031
Figure 20: North America Thrombectomy Devices Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 21: North America Thrombectomy Devices Market Attractiveness, by Product Type, 2023–2031
Figure 22: North America Thrombectomy Devices Market Value Share Analysis, by Device Type, 2022 and 2031
Figure 23: North America Thrombectomy Devices Market Attractiveness, by Device Type, 2023–2031
Figure 24: North America Thrombectomy Devices Market Value Share Analysis, by Application, 2022 and 2031
Figure 25: North America Thrombectomy Devices Market Attractiveness, by Application, 2023–2031
Figure 26: North America Thrombectomy Devices Market Value Share Analysis, by End-user, 2022 and 2031
Figure 27: North America Thrombectomy Devices Market Attractiveness, by End-user, 2023–2031
Figure 28: Europe Thrombectomy Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 29: Europe Thrombectomy Devices Market Value Share (%), by Country/Sub-region, 2022 and 2031
Figure 30: Europe Thrombectomy Devices Market Attractiveness, by Country/Sub-region, 2023–2031
Figure 31: Europe Thrombectomy Devices Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 32: Europe Thrombectomy Devices Market Attractiveness, by Product Type, 2023–2031
Figure 33: Europe Thrombectomy Devices Market Value Share Analysis, by Device Type, 2022 and 2031
Figure 34: Europe Thrombectomy Devices Market Attractiveness, by Device Type, 2023–2031
Figure 35: Europe Thrombectomy Devices Market Value Share Analysis, by Application, 2022 and 2031
Figure 36: Europe Thrombectomy Devices Market Attractiveness, by Application, 2023–2031
Figure 37: Europe Thrombectomy Devices Market Value Share Analysis, by End-user, 2022 and 2031
Figure 38: Europe Thrombectomy Devices Market Attractiveness, by End-user, 2023–2031
Figure 39: Asia Pacific Thrombectomy Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 40: Asia Pacific Thrombectomy Devices Market Value Share (%), by Country/Sub-region, 2022 and 2031
Figure 41: Asia Pacific Thrombectomy Devices Market Attractiveness, by Country/Sub-region, 2023–2031
Figure 42: Asia Pacific Thrombectomy Devices Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 43: Asia Pacific Thrombectomy Devices Market Attractiveness, by Product Type, 2023–2031
Figure 44: Asia Pacific Thrombectomy Devices Market Value Share Analysis, by Device Type, 2022 and 2031
Figure 45: Asia Pacific Thrombectomy Devices Market Attractiveness, by Device Type, 2023–2031
Figure 46: Asia Pacific Thrombectomy Devices Market Value Share Analysis, by Application, 2022 and 2031
Figure 47: Asia Pacific Thrombectomy Devices Market Attractiveness, by Application, 2023–2031
Figure 48: Asia Pacific Thrombectomy Devices Market Value Share Analysis, by End-user, 2022 and 2031
Figure 49: Asia Pacific Thrombectomy Devices Market Attractiveness, by End-user, 2023–2031
Figure 50: Latin America Thrombectomy Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 51: Latin America Thrombectomy Devices Market Value Share (%), by Country/Sub-region, 2022 and 2031
Figure 52: Latin America Thrombectomy Devices Market Attractiveness, by Country/Sub-region, 2023–2031
Figure 53: Latin America Thrombectomy Devices Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 54: Latin America Thrombectomy Devices Market Attractiveness, by Product Type, 2023–2031
Figure 55: Latin America Thrombectomy Devices Market Value Share Analysis, by Device Type, 2022 and 2031
Figure 56: Latin America Thrombectomy Devices Market Attractiveness, by Device Type, 2023–2031
Figure 57: Latin America Thrombectomy Devices Market Value Share Analysis, by Application, 2022 and 2031
Figure 58: Latin America Thrombectomy Devices Market Attractiveness, by Application, 2023–2031
Figure 59: Latin America Thrombectomy Devices Market Value Share Analysis, by End-user, 2022 and 2031
Figure 60: Latin America Thrombectomy Devices Market Attractiveness, by End-user, 2023–2031
Figure 61: Middle East & Africa Thrombectomy Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 62: Middle East & Africa Thrombectomy Devices Market Value Share (%), by Country/Sub-region, 2022 and 2031
Figure 63: Middle East & Africa Thrombectomy Devices Market Attractiveness, by Country/Sub-region, 2023–2031
Figure 64: Middle East & Africa Thrombectomy Devices Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 65: Middle East & Africa Thrombectomy Devices Market Attractiveness, by Product Type, 2023–2031
Figure 66: Middle East & Africa Thrombectomy Devices Market Value Share Analysis, by Device Type, 2022 and 2031
Figure 67: Middle East & Africa Thrombectomy Devices Market Attractiveness, by Device Type, 2023–2031
Figure 68: Middle East & Africa Thrombectomy Devices Market Value Share Analysis, by Application, 2022 and 2031
Figure 69: Middle East & Africa Thrombectomy Devices Market Attractiveness, by Application, 2023–2031
Figure 70: Middle East & Africa Thrombectomy Devices Market Value Share Analysis, by End-user, 2022 and 2031
Figure 71: Middle East & Africa Thrombectomy Devices Market Attractiveness, by End-user, 2023–2031
Figure 72: Global Thrombectomy Devices Market Share Analysis, by Company, 2021
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Thrombectomy Devices Market
